bevacizumab,cetuximab
roche,eli lilly
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'fire-4', 'improve ']
secondary endpoint of fire-4 . switch maintenance to 5fu/bev after folfiri/cetux in 1st line crc does not improve mpfs. expected?! 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine